1	¿	¿	Fia	-	-	0-1	589_QUEST_clinical_caseMIR	SENT1	-	-
2	Cuál	cuál	PT0CS000	-	-	1-5	589_QUEST_clinical_caseMIR	SENT1	-	-
3	es	ser	VSIP3S0	-	-	6-8	589_QUEST_clinical_caseMIR	SENT1	-	-
4	el	el	DA0MS0	-	-	9-11	589_QUEST_clinical_caseMIR	SENT1	-	-
5	diagnóstico	diagnóstico	NCMS000	C0011900	entidad_observable	12-23	589_QUEST_clinical_caseMIR	SENT1	-	-
6	más	más	RG	C0205172	calificador	24-27	589_QUEST_clinical_caseMIR	SENT1	-	-
7	probable	probable	AQ0CS0	C0332148	calificador	28-36	589_QUEST_clinical_caseMIR	SENT1	-	-
8	de	de	SPS00	C0332285	atributo	37-39	589_QUEST_clinical_caseMIR	SENT1	-	-
9	un	un		C0205447_1	calificador_1	40-42	589_QUEST_clinical_caseMIR	SENT1	-	-
10	paciente	paciente	NCCS000	C0030705	persona	43-51	589_QUEST_clinical_caseMIR	SENT1	-	-
11	con	con	SPS00	C0332287	atributo	52-55	589_QUEST_clinical_caseMIR	SENT1	-	-
12	trombopenia	trombopenia	NCFS000	C0040034_1	trastorno_1	56-67	589_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
13	progresiva	progresivo	AQ0FS0	C0205329	calificador	68-78	589_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
14	,	,	Fc	-	-	78-79	589_QUEST_clinical_caseMIR	SENT1	-	-
15	niveles	nivel	NCMP000	C0456079	atributo	80-87	589_QUEST_clinical_caseMIR	SENT1	-	-
16	de	de	SPS00	C0332285	atributo	88-90	589_QUEST_clinical_caseMIR	SENT1	-	-
17	fibrinogeno	fibrinogeno	NCMS000	-	-	91-102	589_QUEST_clinical_caseMIR	SENT1	-	-
18	bajos	bajo	AQ0MP0	C0205251	calificador	103-108	589_QUEST_clinical_caseMIR	SENT1	-	-
19	,	,	Fc	-	-	108-109	589_QUEST_clinical_caseMIR	SENT1	-	-
20	alargamiento	alargamiento	NCMS000	C0441592	calificador	110-122	589_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
21	de	de	SPS00	C0332285	atributo	123-125	589_QUEST_clinical_caseMIR	SENT1	-	-
22	los	el	DA0MP0	-	-	126-129	589_QUEST_clinical_caseMIR	SENT1	-	-
23	tiempos	tiempo	NCMP000	C0040223#C3541383	calificador#atributo#metadato_fundacional	130-137	589_QUEST_clinical_caseMIR	SENT1	-	-
24	de	de	SPS00	C0332285	atributo	138-140	589_QUEST_clinical_caseMIR	SENT1	-	-
25	protrombina	protrombina	NCFS000	C0033706	sustancia	141-152	589_QUEST_clinical_caseMIR	SENT1	-	-
26	y	y	CC	C1706368	calificador	153-154	589_QUEST_clinical_caseMIR	SENT1	-	-
27	tromboplastina	tromboplastina	NCFS000	C0040048	producto#sustancia	155-169	589_QUEST_clinical_caseMIR	SENT1	-	-
28	parcial	parcial	AQ0CS0	C0728938#C0205257#C0728939	calificador	170-177	589_QUEST_clinical_caseMIR	SENT1	-	-
29	activada	activar	VMP00SF	-	-	178-186	589_QUEST_clinical_caseMIR	SENT1	-	-
30	,	,	Fc	-	-	186-187	589_QUEST_clinical_caseMIR	SENT1	-	-
31	aumento	aumento	NCMS000	C0442805	calificador	188-195	589_QUEST_clinical_caseMIR	SENT1	-	-
32	de	de	SPS00	C0332285	atributo	196-198	589_QUEST_clinical_caseMIR	SENT1	-	-
33	los	el	DA0MP0	-	-	199-202	589_QUEST_clinical_caseMIR	SENT1	-	-
34	dímeros-D	dímeros-d	NCFS000	-	-	203-212	589_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
35	y	y	CC	C1706368	calificador	213-214	589_QUEST_clinical_caseMIR	SENT1	-	-
36	esquistocitos	esquistocito	NCMP000	C0221282	célula	215-228	589_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
37	en	en	SPS00	C1720294#C0332285	calificador#atributo	229-231	589_QUEST_clinical_caseMIR	SENT1	-	-
38	el	el	DA0MS0	-	-	232-234	589_QUEST_clinical_caseMIR	SENT1	-	-
39	frotis	frotis	NCMN000	-	-	235-241	589_QUEST_clinical_caseMIR	SENT1	-	-
40	de	de	SPS00	C0332285	atributo	242-244	589_QUEST_clinical_caseMIR	SENT1	-	-
41	sangre	sangre	NCFS000	C0229664_1	sustancia_1	245-251	589_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
42	periférica	periférico	AQ0FS0	C0229664_2	sustancia_2	252-262	589_QUEST_clinical_caseMIR	SENT1	I-Estructura_Corporal	-
43	?	?	Fit	-	-	262-263	589_QUEST_clinical_caseMIR	SENT1	-	-

